Literature DB >> 14688087

Sialylation of lipooligosaccharides promotes biofilm formation by nontypeable Haemophilus influenzae.

W Edward Swords1, Miranda L Moore, Luciana Godzicki, Gail Bukofzer, Michael J Mitten, Jessica VonCannon.   

Abstract

Nontypeable Haemophilus influenzae (NTHi) is a major cause of opportunistic respiratory tract infections, including otitis media and bronchitis. The persistence of NTHi in vivo is thought to involve bacterial persistence in a biofilm community. Therefore, there is a need for further definition of bacterial factors contributing to biofilm formation by NTHi. Like other bacteria inhabiting host mucosal surfaces, NTHi has on its surface a diverse array of lipooligosaccharides (LOS) that influence host-bacterial interactions. In this study, we show that LOS containing sialic (N-acetyl-neuraminic) acid promotes biofilm formation by NTHi in vitro and bacterial persistence within the middle ear or lung in vivo. LOS from NTHi in biofilms was sialylated, as determined by comparison of electrophoretic mobilities and immunochemical reactivities before and after neuraminidase treatment. Biofilm formation was significantly reduced in media lacking sialic acid, and a siaB (CMP-sialic acid synthetase) mutant was deficient in biofilm formation in three different in vitro model systems. The persistence of an asialylated siaB mutant was attenuated in a gerbil middle ear infection model system, as well as in a rat pulmonary challenge model system. These data show that sialylated LOS glycoforms promote biofilm formation by NTHi and persistence in vivo.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14688087      PMCID: PMC343998          DOI: 10.1128/IAI.72.1.106-113.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  68 in total

1.  Non-typeable Haemophilus influenzae adhere to and invade human bronchial epithelial cells via an interaction of lipooligosaccharide with the PAF receptor.

Authors:  W E Swords; B A Buscher; K Ver Steeg Ii; A Preston; W A Nichols; J N Weiser; B W Gibson; M A Apicella
Journal:  Mol Microbiol       Date:  2000-07       Impact factor: 3.501

Review 2.  Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review.

Authors:  S Sethi; T F Murphy
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

3.  Neuraminidase expressed by Streptococcus pneumoniae desialylates the lipopolysaccharide of Neisseria meningitidis and Haemophilus influenzae: a paradigm for interbacterial competition among pathogens of the human respiratory tract.

Authors:  Elizabeth A Shakhnovich; Samantha J King; Jeffrey N Weiser
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

4.  Identification of a lipopolysaccharide alpha-2,3-sialyltransferase from Haemophilus influenzae.

Authors:  D W Hood; A D Cox; M Gilbert; K Makepeace; S Walsh; M E Deadman; A Cody; A Martin; M Månsson; E K Schweda; J R Brisson; J C Richards; E R Moxon; W W Wakarchuk
Journal:  Mol Microbiol       Date:  2001-01       Impact factor: 3.501

5.  Evaluation of phase variation of nontypeable Haemophilus influenzae lipooligosaccharide during nasopharyngeal colonization and development of otitis media in the chinchilla model.

Authors:  H H Tong; L E Blue; M A James; Y P Chen; T F DeMaria
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

6.  Sialic acid metabolism's dual function in Haemophilus influenzae.

Authors:  E Vimr; C Lichtensteiger; S Steenbergen
Journal:  Mol Microbiol       Date:  2000-06       Impact factor: 3.501

7.  Passive transfer of antiserum specific for immunogens derived from a nontypeable Haemophilus influenzae adhesin and lipoprotein D prevents otitis media after heterologous challenge.

Authors:  B J Kennedy; L A Novotny; J A Jurcisek; Y Lobet; L O Bakaletz
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

8.  The Haemophilus influenzae Hap autotransporter mediates microcolony formation and adherence to epithelial cells and extracellular matrix via binding regions in the C-terminal end of the passenger domain.

Authors:  Doran L Fink; Amy Z Buscher; Bruce Green; Phillip Fernsten; Joseph W St Geme
Journal:  Cell Microbiol       Date:  2003-03       Impact factor: 3.715

9.  Prevalence and distribution of adhesins in invasive non-type b encapsulated Haemophilus influenzae.

Authors:  Carina A Rodriguez; Vasanthi Avadhanula; Amy Buscher; Arnold L Smith; Joseph W St Geme; Elisabeth E Adderson
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

10.  Biofilm formation by nontypeable Haemophilus influenzae: strain variability, outer membrane antigen expression and role of pili.

Authors:  Timothy F Murphy; Charmaine Kirkham
Journal:  BMC Microbiol       Date:  2002-04-15       Impact factor: 3.605

View more
  64 in total

Review 1.  Bacterial biofilms in the upper airway - evidence for role in pathology and implications for treatment of otitis media.

Authors:  Lauren O Bakaletz
Journal:  Paediatr Respir Rev       Date:  2012-05-27       Impact factor: 2.726

2.  Multiple consecutive lavage samplings reveal greater burden of disease and provide direct access to the nontypeable Haemophilus influenzae biofilm in experimental otitis media.

Authors:  Magali Leroy; Howard Cabral; Marisol Figueira; Valérie Bouchet; Heather Huot; Sanjay Ram; Stephen I Pelton; Richard Goldstein
Journal:  Infect Immun       Date:  2007-05-21       Impact factor: 3.441

3.  Intercellular adhesion and biocide resistance in nontypeable Haemophilus influenzae biofilms.

Authors:  Era A Izano; Suhagi M Shah; Jeffrey B Kaplan
Journal:  Microb Pathog       Date:  2009-02-04       Impact factor: 3.738

4.  LuxS promotes biofilm maturation and persistence of nontypeable haemophilus influenzae in vivo via modulation of lipooligosaccharides on the bacterial surface.

Authors:  Chelsie E Armbruster; Wenzhou Hong; Bing Pang; Kristin E Dew; Richard A Juneau; Matthew S Byrd; Cheraton F Love; Nancy D Kock; W Edward Swords
Journal:  Infect Immun       Date:  2009-06-29       Impact factor: 3.441

5.  Incorporation of phosphorylcholine into the lipooligosaccharide of nontypeable Haemophilus influenzae does not correlate with the level of biofilm formation in vitro.

Authors:  Carmen Puig; Sara Marti; Peter W M Hermans; Marien I de Jonge; Carmen Ardanuy; Josefina Liñares; Jeroen D Langereis
Journal:  Infect Immun       Date:  2014-01-22       Impact factor: 3.441

6.  Induction of the Yersinia pestis PhoP-PhoQ regulatory system in the flea and its role in producing a transmissible infection.

Authors:  Roberto Rebeil; Clayton O Jarrett; James D Driver; Robert K Ernst; Petra C F Oyston; B Joseph Hinnebusch
Journal:  J Bacteriol       Date:  2013-02-22       Impact factor: 3.490

7.  Phosphorylcholine expression by nontypeable Haemophilus influenzae correlates with maturation of biofilm communities in vitro and in vivo.

Authors:  Wenzhou Hong; Bing Pang; Shayla West-Barnette; W Edward Swords
Journal:  J Bacteriol       Date:  2007-06-15       Impact factor: 3.490

8.  Application of capillary electrophoresis mass spectrometry and liquid chromatography multiple-step tandem electrospray mass spectrometry to profile glycoform expression during Haemophilus influenzae pathogenesis in the chinchilla model of experimental otitis media.

Authors:  Susanna L Lundström; Jianjun Li; Martin Månsson; Marisol Figueira; Magali Leroy; Richard Goldstein; Derek W Hood; E Richard Moxon; James C Richards; Elke K H Schweda
Journal:  Infect Immun       Date:  2008-05-05       Impact factor: 3.441

9.  Lipooligosaccharides containing phosphorylcholine delay pulmonary clearance of nontypeable Haemophilus influenzae.

Authors:  Bing Pang; Dana Winn; Ryan Johnson; Wenzhou Hong; Shayla West-Barnette; Nancy Kock; W Edward Swords
Journal:  Infect Immun       Date:  2008-03-17       Impact factor: 3.441

10.  Sialic acid mediated transcriptional modulation of a highly conserved sialometabolism gene cluster in Haemophilus influenzae and its effect on virulence.

Authors:  Gaynor A Jenkins; Marisol Figueira; Gaurav A Kumar; Wendy A Sweetman; Katherine Makepeace; Stephen I Pelton; Richard Moxon; Derek W Hood
Journal:  BMC Microbiol       Date:  2010-02-16       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.